Oral Presentations 1- Anti-infective drugs

10:30 • 151 • Pharmacologist-Guided Meropenem Therapeutic Drug Monitoring and PK/PD Target Attainment in Critically Ill Patients > Y. Youssef Libiad 10:43 • 483 • Implementation of a Multidisciplinary Therapeutic Drug Monitoring Pathway for Trimethoprim-Sulfamethoxazole in Non-HIV Pneumocystis Pneumonia: A Prospective Real-World Study > X. Xiaohan XU 10:55 • 519 • Individualized dosing regimen of ceftazidime-avibactam stratified by CRRT intensity and residual renal function: A population pharmacokinetic study integrating CRRT clearance parameters > T. Tingting Wu 11:09 • 237 • One model to dose them all: a population pharmacokinetic model for multiple aminoglycosides across the human lifespan > J. Jasmine Hughes 11:22 • 138 • Modeling of rifampicin exposure, bacilliary elimination rate and intensive phase MGIT culture conversion of Vietnamese non-MDR pulmonary tuberculosis patients > S. Son Nhat BUI 11:35 • 72 • Population pharmacokinetic modeling and dose optimization of linezolid in plasma and cerebrospinal fluid of postoperative neurosurgical patients > Y. Ying Zhang 11:48 • 12 • A multicentre, randomised controlled clinical trial to study the impact of bedside model-informed precision dosing of vancomycin in severely ill neonates and children– BENEFICIAL trial. > P. Pieter DE COCK